Cargando…
The 9aaTAD Is Exclusive Activation Domain in Gal4
The Gal4 protein is a well-known prototypic acidic activator that has multiple activation domains. We have previously identified a new activation domain called the nine amino acid transactivation domain (9aaTAD) in Gal4 protein. The family of the 9aaTAD activators currently comprises over 40 members...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215927/ https://www.ncbi.nlm.nih.gov/pubmed/28056036 http://dx.doi.org/10.1371/journal.pone.0169261 |
_version_ | 1782491834207961088 |
---|---|
author | Piskacek, Martin Havelka, Marek Rezacova, Martina Knight, Andrea |
author_facet | Piskacek, Martin Havelka, Marek Rezacova, Martina Knight, Andrea |
author_sort | Piskacek, Martin |
collection | PubMed |
description | The Gal4 protein is a well-known prototypic acidic activator that has multiple activation domains. We have previously identified a new activation domain called the nine amino acid transactivation domain (9aaTAD) in Gal4 protein. The family of the 9aaTAD activators currently comprises over 40 members including p53, MLL, E2A and other members of the Gal4 family; Oaf1, Pip2, Pdr1 and Pdr3. In this study, we revised function of all reported Gal4 activation domains. Surprisingly, we found that beside of the activation domain 9aaTAD none of the previously reported activation domains had considerable transactivation potential and were not involved in the activation of transcription. Our results demonstrated that the 9aaTAD domain is the only decisive activation domain in the Gal4 protein. We found that the artificial peptides included in the original Gal4 constructs were results of an unintended consequence of cloning that were responsible for the artificial transcriptional activity. Importantly, the activation domain 9aaTAD, which is the exclusive activation domain in Gal4, is also the central part of a conserved sequence recognized by the inhibitory protein Gal80. We propose a revision of the Gal4 regulation, in which the activation domain 9aaTAD is directly linked to both activation function and Gal80 mediated inhibition. |
format | Online Article Text |
id | pubmed-5215927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-52159272017-01-19 The 9aaTAD Is Exclusive Activation Domain in Gal4 Piskacek, Martin Havelka, Marek Rezacova, Martina Knight, Andrea PLoS One Research Article The Gal4 protein is a well-known prototypic acidic activator that has multiple activation domains. We have previously identified a new activation domain called the nine amino acid transactivation domain (9aaTAD) in Gal4 protein. The family of the 9aaTAD activators currently comprises over 40 members including p53, MLL, E2A and other members of the Gal4 family; Oaf1, Pip2, Pdr1 and Pdr3. In this study, we revised function of all reported Gal4 activation domains. Surprisingly, we found that beside of the activation domain 9aaTAD none of the previously reported activation domains had considerable transactivation potential and were not involved in the activation of transcription. Our results demonstrated that the 9aaTAD domain is the only decisive activation domain in the Gal4 protein. We found that the artificial peptides included in the original Gal4 constructs were results of an unintended consequence of cloning that were responsible for the artificial transcriptional activity. Importantly, the activation domain 9aaTAD, which is the exclusive activation domain in Gal4, is also the central part of a conserved sequence recognized by the inhibitory protein Gal80. We propose a revision of the Gal4 regulation, in which the activation domain 9aaTAD is directly linked to both activation function and Gal80 mediated inhibition. Public Library of Science 2017-01-05 /pmc/articles/PMC5215927/ /pubmed/28056036 http://dx.doi.org/10.1371/journal.pone.0169261 Text en © 2017 Piskacek et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Piskacek, Martin Havelka, Marek Rezacova, Martina Knight, Andrea The 9aaTAD Is Exclusive Activation Domain in Gal4 |
title | The 9aaTAD Is Exclusive Activation Domain in Gal4 |
title_full | The 9aaTAD Is Exclusive Activation Domain in Gal4 |
title_fullStr | The 9aaTAD Is Exclusive Activation Domain in Gal4 |
title_full_unstemmed | The 9aaTAD Is Exclusive Activation Domain in Gal4 |
title_short | The 9aaTAD Is Exclusive Activation Domain in Gal4 |
title_sort | 9aatad is exclusive activation domain in gal4 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215927/ https://www.ncbi.nlm.nih.gov/pubmed/28056036 http://dx.doi.org/10.1371/journal.pone.0169261 |
work_keys_str_mv | AT piskacekmartin the9aatadisexclusiveactivationdomainingal4 AT havelkamarek the9aatadisexclusiveactivationdomainingal4 AT rezacovamartina the9aatadisexclusiveactivationdomainingal4 AT knightandrea the9aatadisexclusiveactivationdomainingal4 AT piskacekmartin 9aatadisexclusiveactivationdomainingal4 AT havelkamarek 9aatadisexclusiveactivationdomainingal4 AT rezacovamartina 9aatadisexclusiveactivationdomainingal4 AT knightandrea 9aatadisexclusiveactivationdomainingal4 |